Skip to main content

Animations

MJFF Publications

1211 - 1220 of 8587 Results
Title
Year
  • Year
  • 2023
  • 2015
  • 2017
  • 2008
  • 2013
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • Summary Details
    RESTRICTED
    Title: Enhancing Diversity and Inclusion in Clinical Trials
    Journal Name: Clinical Pharmacology & Therapeutics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/cpt.2819
    Citation Count: 17
  • Summary Details
    RESTRICTED
    Title: Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson’s disease patients? A Systematic Review
    Journal Name: Neuropsychology Review
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s11065-015-9307-8
    Citation Count: 18
  • Summary Details
    RESTRICTED
    Title: Neuropsychiatric symptoms in untreated Parkinson’s disease
    Journal Name: Neuropsychiatric Disease and Treatment
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.2147/ndt.s130997
    Citation Count: 41
  • Summary Details
    RESTRICTED
    Title: Promise of mGluR2/3 activators in psychiatry
    Journal Name: Neuropsychopharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/npp.2008.156
    Citation Count: 37
  • Summary Details
    RESTRICTED
    Title: Aberrant Protein S-Nitrosylation in Neurodegenerative Diseases
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.neuron.2013.05.005
    Citation Count: 305
  • Summary Details
    RESTRICTED
    Title: Glycolysis: The Next Big Breakthrough in Parkinson’s Disease
    Journal Name: Neurotoxicity Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s12640-022-00579-3
    Best OA location URL:
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Functional tremor
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jns.2022.120208
    Citation Count: 11
  • Summary Details
    RESTRICTED
    Title: Corrigendum to “Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys” [EBioMedicine 2020; 59:102944]
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2021.103731
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Emerging roles of endoplasmic reticulum proteostasis in brain development
    Journal Name: Cells & Development
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.cdev.2022.203781
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: REM sleep behavior and olfactory dysfunction: Enhancing the utility and translation of animal models in the search for precision medicines for Parkinson's disease
    Journal Name: Neuroscience & Biobehavioral Reviews
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neubiorev.2022.104897
    Best OA location URL:
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.